There’s a moment in every breast cancer journey that looks like an ending. You ring the bell. You bang the gong. Everyone claps. And then you go home, and the hardest part — the part nobody warned you about — life after breast cancer is only just beginning.
I’ve lived that moment. And this month, the second of two new pieces of academic research landed that put language and evidence around something I’ve felt in my body for four years now: the fallout from a breast cancer diagnosis doesn’t end when treatment does. It just changes shape.
I want to walk you through what these studies found, why they matter, and — because AskEllyn was always meant to be conversational, not clinical — what they stirred up for me personally about life after breast cancer.
Study One: Mapping What Falls Through the Cracks in Life After Breast Cancer
The first study, “Beyond breast cancer: mapping unmet needs and advancing an evidence-based framework of survivorship care”, published in the journal Supportive Care in Cancer in April 2026, is led by Dr. Amina Silva at Brock University — the same researcher who co-leads the Canadian Cancer Society–funded study on AskEllyn. Her team set out to answer a deceptively simple question: what women survivors need in life after breast cancer that they aren’t getting?
To answer it, they combed through over 13,000 studies and narrowed the field to 170 that met their criteria. What emerged was a map of six categories of unmet need: physical symptoms, psychosocial and emotional needs, information gaps, healthcare support, relational and sexual health, and financial or occupational strain.
Two categories stood out from the rest. Physical symptoms showed up in about a third of the studies reviewed. Psychosocial and emotional distress was nearly as common. In other words, long after the physical wounds close, the emotional ones are still very much open — and the research confirms that this isn’t rare or unusual. It’s the norm.
The researchers didn’t stop at naming the problem. They proposed a three-part framework for life after breast cancer survivorship care going forward: screen everyone for these needs as a matter of course, match people with the right kind of support for what they’re actually experiencing, and keep checking back in over time rather than treating survivorship as a single box to tick.
Study Two: What AskEllyn Teaches About Designing Care
The second study, “Designing for Care, Not Just Function: Lessons From a Non-Clinical Artificial Intelligence Innovation in Person-Centred Fundamental Care”, published in the Journal of Advanced Nursing in July 2026, takes a different angle. Co-authored by Dr. Silva, Patrick Belliveau of Gambit Technologies, and me, it uses AskEllyn as a real-world case study to ask a bigger question: what does it actually take for artificial intelligence to deliver care during life after breast cancer that’s centred on the whole person, not just their symptoms or their data? (If you’re curious how that companion model works in practice, I’ve written before about how AI companions are transforming the breast cancer journey.)
I want to pause on that “co-authored by… me” for a second, because I still haven’t quite gotten used to writing it. Three years ago I was a patient with a hot water bottle and a legal pad, trying to make sense of a diagnosis. I never once imagined that journey would end with my name on a peer-reviewed nursing journal, sitting alongside a nurse-researcher and a technologist, contributing to how the field thinks about AI and care. It’s one of the stranger and more meaningful turns this whole experience has taken.
The paper argues that care shouldn’t be something bolted onto a piece of technology after the fact. It should be a design constraint from the very first sketch — baked in from day one, the same way you’d design for safety or accuracy. It’s a research validation of something I’ve believed since the first conversation I imagined AskEllyn having: technology built without lived experience in the room will always miss something that matters.
Why This Matters for Our Community
Reading these two studies side by side felt like watching a circle close. One confirms, in careful academic language, that the psychosocial and emotional weight of this disease is real, common, and under-addressed. The other examines whether AI companionship, built the way AskEllyn was built, might be part of how we finally address it. It also echoes a theme I covered when I recapped ASCO 2026’s survivorship sessions: surviving cancer and living well after cancer are not the same thing, and the research community is finally catching up to what patients have known all along.
Here’s what I’d want you to take from this if you’re navigating your own diagnosis or life after breast cancer right now:
- What you’re feeling has a name, and it has data behind it. If you finished treatment and expected to feel like “yourself” again, only to find yourself more anxious, more fatigued, or more unmoored than you expected — you are not broken, and you are not alone. This is one of the most well-documented experiences in survivorship research.
- Physical symptoms don’t disappear on schedule. Nearly a third of the studies reviewed centred on ongoing physical symptom burden. If your body still doesn’t feel like yours months or years out, that’s worth bringing to your care team, not something to quietly tolerate.
- Screening shouldn’t be a one-time event. The research calls for ongoing, repeated check-ins on emotional and physical wellbeing — not a single form at your last appointment. If your care team isn’t asking, it’s okay to bring it up yourself.
- You deserve care that was designed with people like you in the room. Whether that’s a therapist, a support group, or a tool like AskEllyn, look for support in life after breast cancer that was shaped by lived experience, not just clinical assumption.
- Relationships absorb some of this weight too. Psychosocial fallout rarely stays contained to the person diagnosed — I’ve written separately about relationship strain after a breast cancer diagnosis if that’s part of what you’re navigating.
A Personal Note
I’ll be honest with you: writing the “significance” section above was easier than writing this one.
I am four years out from my diagnosis. I have rung the bell, banged the gong, written the book, built the company. By every visible measure, I am a survivorship success story.
And I am currently seeing a trauma therapist.
One session of EMDR — a therapy that helps the brain process traumatic memories — and I am in tears within seconds. Not dramatic tears. Not for effect. Just the body doing what bodies do when they’ve been holding something for a very long time and are finally given permission to put it down, even for a moment.
I share this not because I want sympathy, but because I think it’s exactly the kind of thing the psychosocial data in that first study is trying to capture in numbers, and exactly the kind of thing a checkbox on a form will never fully hold. Four years is a long time by most measures. It is nothing at all by the measure of what a body remembers — something I tried to unpack in more depth in Your Nervous System After Cancer: Why Survivorship Still Feels So Hard, if you want to go deeper on the biology of why this lingers.
If you are further out from treatment than anyone around you expects you to still be “dealing with this,” I want you to hear this clearly: the research backs you up. This is common. This is documented. This is not a personal failing or a sign that you’re not healing correctly. It’s simply what this disease asks of us, long after the visible parts of the fight are behind us.
No one diagnosed walks alone — and that includes the walk that keeps going long after everyone else assumes it’s over.
— Ellyn
This post touches on trauma and mental health related to life after breast cancer. If anything here brings up difficult feelings for you, please know that support is available, and AskEllyn is here any time you need someone to talk to who truly understands.
Related Reading
- Your Nervous System After Cancer: Why Survivorship Still Feels So Hard
- ASCO 2026 and Breast Cancer: Survivorship, Fear of Recurrence, and the Growing Role of AI in Cancer Care
- What a Major New Study Confirms: Breast Cancer Survival Rates Are Better with Standard, Evidence-Based Treatment
- How AI Companions Are Transforming the Breast Cancer Journey
- Relationship Strain and Breast Cancer: The Hidden Side Effect
- Browse more in Mental Health and Breast Cancer Research
